ConductScience.org, home

Paper42226136

Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma.

Yang Y and 9 others. BMC Gastroenterol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma. Papers, record 42226136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma.
PubMed
Journal
BMC Gastroenterol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang YYuanping
2Liang WWeiming
3Pang JJinshu
4Bai XXiumei
5Wen RRong
6Wu YYuquan
7Peng JJinbo
8Yang HHong
9He YYun
10Gao RRuizhi

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CholangiocarcinomaMajor topic
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Bile Duct NeoplasmsMajor topic
Humans
Radiomics
Ultrasonography
Male
Female
Middle Aged
Aged
Retrospective Studies
Predictive Value of Tests

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
202410598008Guangxi Medical University Undergraduate Innovation and Entrepreneurship Training ProgramPubMed
No.YYZS2020024the Clinical Research Climbing Project of The First Affiliated Hospital of Guangxi Medical UniversityPubMed

Source PubMed

Download CSV of grants

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116613323Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma.Hum Pathol2006https://conductscience.org/library/papers/16613323PubMed
231335362Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.Am J Gastroenterol2019https://conductscience.org/library/papers/31335362PubMed
334234239Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma.Sci Rep2021https://conductscience.org/library/papers/34234239PubMed
432385649Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?Eur Radiol2020https://conductscience.org/library/papers/32385649PubMed
531512867Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values.J Med Chem2020https://conductscience.org/library/papers/31512867PubMed
636112193Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.Eur Radiol2023https://conductscience.org/library/papers/36112193PubMed
730799097Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population.Clin Radiol2019https://conductscience.org/library/papers/30799097PubMed
829667093The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study.J Gastrointest Surg2018https://conductscience.org/library/papers/29667093PubMed
936836479Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma.J Pers Med2023https://conductscience.org/library/papers/36836479PubMed
1035976399Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.Eur Radiol2022https://conductscience.org/library/papers/35976399PubMed
1118284443Management of combined hepatocellular and cholangiocarcinoma.Int J Clin Pract2008https://conductscience.org/library/papers/18284443PubMed
1238319170What a Radiologist Needs to Know About Radiomics, Standardization, and Reproducibility.Radiology2024https://conductscience.org/library/papers/38319170PubMed
1339759152Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound.Front Oncol2024https://conductscience.org/library/papers/39759152PubMed
1426917546Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.BMC Cancer2016https://conductscience.org/library/papers/26917546PubMed
1535397928Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics.Ultrasound Med Biol2022https://conductscience.org/library/papers/35397928PubMed
1639732135An MRI-Based Radiomics Model for Preoperative Prediction of Microvascular Invasion and Outcome in Intrahepatic Cholangiocarcinoma.Eur J Radiol2025https://conductscience.org/library/papers/39732135PubMed
1735392229Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures.Front Oncol2022https://conductscience.org/library/papers/35392229PubMed
1836966771A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma.Eur J Gastroenterol Hepatol2023https://conductscience.org/library/papers/36966771PubMed
1930689032Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.Eur Radiol2019https://conductscience.org/library/papers/30689032PubMed
2033837585
Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
Histopathology2021https://conductscience.org/library/papers/33837585PubMed

See all 29 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226136

GET https://conductscience.org/api/papers/v1/42226136/references?page=2